Quest PharmaTech股价周三暴跌25%，至0.03加元，交易量激增414%，但未提供任何解释。 Quest PharmaTech shares plunged 25% to C$0.03 on Wednesday amid a 414% surge in trading volume, with no explanation provided.

Quest PharmaTech（CVE：QPT）股价周三下跌25%，至0.03加元，交易量较平均水平激增414%。 Quest PharmaTech (CVE:QPT) shares dropped 25% to C$0.03 on Wednesday, with trading volume surging 414% above average. 该公司的重点是癌症治疗,包括对Oregovomab的第三阶段试验,主要候选人针对MUC16,其市场上限为507万科多巴元,债务与股本比率为4.35。 The company, focused on cancer therapeutics including Phase III trials for Oregovomab and a lead candidate targeting MUC16, has a market cap of C$5.07 million and a debt-to-equity ratio of 4.35. 没有提供下降的理由。 No reason for the decline was provided.